BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Ovarian cancer AND KRAS, C-K-RAS, 3845, P01116, NS3, KI-RAS, KRAS2, K-RAS4A, K-RAS2A, K-RAS4B, KRAS1, K-RAS2B, RASK2 AND Diagnosis
92 results:

  • 1. Serial Circulating Tumor DNA Analysis with a Tumor-Naïve Next-Generation Sequencing Panel Detects Minimal Residual Disease and Predicts Outcome in ovarian cancer.
    Heo J; Kim YN; Shin S; Lee K; Lee JH; Lee YJ; Choi Z; Park J; Min S; Kim SW; Choi JR; Kim S; Lee ST; Lee JY
    Cancer Res; 2024 Feb; 84(3):468-478. PubMed ID: 38038965
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The copy number and mutational landscape of recurrent ovarian high-grade serous carcinoma.
    Smith P; Bradley T; Gavarró LM; Goranova T; Ennis DP; Mirza HB; De Silva D; Piskorz AM; Sauer CM; Al-Khalidi S; Funingana IG; Reinius MAV; Giannone G; Lewsley LA; Stobo J; McQueen J; Bryson G; Eldridge M; ; Macintyre G; Markowetz F; Brenton JD; McNeish IA
    Nat Commun; 2023 Jul; 14(1):4387. PubMed ID: 37474499
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Histological and Genetic Diversity in ovarian Mucinous Carcinomas: A Pilot Study.
    Razia S; Nakayama K; Yamashita H; Ishibashi T; Ishikawa M; Kanno K; Sato S; Kyo S
    Curr Oncol; 2023 Apr; 30(4):4052-4059. PubMed ID: 37185420
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Extrauterine Mesonephric-like Carcinoma: A Comprehensive Single Institution Study of 33 Cases.
    Euscher ED; Marques-Piubelli ML; Ramalingam P; Wistuba I; Lawson BC; Frumovitz M; Malpica A
    Am J Surg Pathol; 2023 Jun; 47(6):635-648. PubMed ID: 37026792
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Primary Mucinous Tumors of the Ovary: An Interobserver Reproducibility and Detailed Molecular Study Reveals Significant Overlap Between Diagnostic Categories.
    Dundr P; Bártů M; Bosse T; Bui QH; Cibula D; Drozenová J; Fabian P; Fadare O; Hausnerová J; Hojný J; Hájková N; Jakša R; Laco J; Lax SF; Matěj R; Méhes G; Michálková R; Šafanda A; Němejcová K; Singh N; Stolnicu S; Švajdler M; Zima T; Stružinská I; McCluggage WG
    Mod Pathol; 2023 Jan; 36(1):100040. PubMed ID: 36788074
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Genomic profiling in low grade serous ovarian cancer: Identification of novel markers for disease diagnosis and therapy.
    ElNaggar A; Robins D; Baca Y; Arguello D; Ulm M; Arend R; Mantia-Smaldone G; Chu C; Winer I; Holloway R; Krivak T; Jones N; Galvan-Turner V; Herzog TJ; Brown J
    Gynecol Oncol; 2022 Nov; 167(2):306-313. PubMed ID: 36229265
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Clinico-genomic Characterization of ATM and HRD in Pancreas cancer: Application for Practice.
    Park W; O'Connor CA; Bandlamudi C; Forman D; Chou JF; Umeda S; Reyngold M; Varghese AM; Keane F; Balogun F; Yu KH; Kelsen DP; Crane C; Capanu M; Iacobuzio-Donahue C; O'Reilly EM
    Clin Cancer Res; 2022 Nov; 28(21):4782-4792. PubMed ID: 36040493
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Clinical characteristics and molecular aspects of low-grade serous ovarian and peritoneal cancer: a multicenter, observational, retrospective analysis of MITO Group (MITO 22).
    Musacchio L; Califano D; Bartoletti M; Arenare L; Lorusso D; Losito NS; Cormio G; Greggi S; Raspagliesi F; Valabrega G; Salutari V; Pisano C; Spina A; Russo D; Del Sesto M; Canzonieri V; Ferraù F; Zannoni GF; Loizzi V; Ghizzoni V; Casanova C; Tuninetti V; Ducceschi M; Del Vecchio V; Scalone S; Priolo D; Perrone F; Scambia G; Pignata S
    Br J Cancer; 2022 Nov; 127(8):1479-1486. PubMed ID: 35869143
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Low-grade serous carcinoma detected from intraoperative peritoneal washings: Cytological findings and detection of kras mutation.
    Yamamoto E; Warigaya K; Kinoshita Y; Yamamoto A; Murata SI
    Cancer Rep (Hoboken); 2022 Oct; 5(10):e1676. PubMed ID: 35801373
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. The genomic landscape of low-grade serous ovarian/peritoneal carcinoma and its impact on clinical outcomes.
    Gershenson DM; Sun CC; Westin SN; Eyada M; Cobb LP; Nathan LC; Sood AK; Malpica A; Hillman RT; Wong KK
    Gynecol Oncol; 2022 Jun; 165(3):560-567. PubMed ID: 35606067
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. MAPK Pathway Genetic Alterations Are Associated with Prolonged Overall Survival in Low-Grade Serous ovarian Carcinoma.
    Manning-Geist B; Gordhandas S; Liu YL; Zhou Q; Iasonos A; Da Cruz Paula A; Mandelker D; Long Roche K; Zivanovic O; Maio A; Kemel Y; Chi DS; O'Cearbhaill RE; Aghajanian C; Weigelt B; Chui MH; Grisham RN
    Clin Cancer Res; 2022 Oct; 28(20):4456-4465. PubMed ID: 35443055
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Genetic diagnosis of pseudomyxoma peritonei originating from mucinous borderline tumor inside an ovarian teratoma.
    Taguchi A; Rokutan H; Oda K; Tanikawa M; Tanimoto S; Sone K; Mori M; Tsuruga T; Kohsaka S; Tatsuno K; Shinozaki-Ushiku A; Miyagawa K; Mano H; Aburatani H; Ushiku T; Osuga Y
    BMC Med Genomics; 2022 Mar; 15(1):51. PubMed ID: 35255903
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Mesonephric-like Endometrial Carcinoma: Results From Immunohistochemical Screening of 300 Endometrial Carcinomas and Carcinosarcomas for This Often Overlooked and Potentially Aggressive Entity.
    Mills AM; Jenkins TM; Howitt BE; Fan J; Ring KL; Cook I
    Am J Surg Pathol; 2022 Jul; 46(7):921-932. PubMed ID: 35195579
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Clinical, Morphologic, and Molecular Features Associated With ovarian Metastases From Pattern A Endocervical Adenocarcinomas.
    Feinberg J; Hodgson A; Abu-Rustum NR; Long Roche K; Park KJ
    Am J Surg Pathol; 2022 Apr; 46(4):509-518. PubMed ID: 34889854
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Progression of Cystadenoma to Mucinous Borderline ovarian Tumor in Young Females: Case Series and Literature Review.
    Beroukhim G; Ozgediz D; Cohen PJ; Hui P; Morotti R; Schwartz PE; Yang-Hartwich ; Vash-Margita A
    J Pediatr Adolesc Gynecol; 2022 Jun; 35(3):359-367. PubMed ID: 34843973
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Highly specific detection of kras single nucleotide polymorphism by asymmetric PCR/SERS assay.
    Lyu N; Rajendran VK; Li J; Engel A; Molloy MP; Wang Y
    Analyst; 2021 Sep; 146(18):5714-5721. PubMed ID: 34515700
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Atypical Endometrial Hyperplasia, Low-grade: "Much ADO About Nothing".
    D'Angelo E; Espinosa I; Cipriani V; Szafranska J; Barbareschi M; Prat J
    Am J Surg Pathol; 2021 Jul; 45(7):988-996. PubMed ID: 34105519
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. An ultrasensitive biosensor for dual-specific DNA based on deposition of polyaniline on a self-assembled multi-functional DNA hexahedral-nanostructure.
    Chen H; Xiang Y; Cai R; Zhang L; Zhang Y; Zhou N
    Biosens Bioelectron; 2021 May; 179():113066. PubMed ID: 33571935
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Simple mucinous cyst: another potential cancer precursor in the pancreas? Case report with molecular characterization and systematic review of the literature.
    Milanetto AC; Tonello AS; Valotto G; Munari G; Luchini C; Fassan M; Pasquali C
    Virchows Arch; 2021 Jul; 479(1):179-189. PubMed ID: 33511431
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. A comprehensive analysis of somatic alterations in Chinese ovarian cancer patients.
    Zhang Y; Shi X; Zhang J; Chen X; Zhang P; Liu A; Zhu T
    Sci Rep; 2021 Jan; 11(1):387. PubMed ID: 33432021
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 5.